Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mepolizumab in Bullous Pemphigoid
NCT01705795Phase 2Completed
- Sponsor
- Insel Gruppe
- Start
- Feb 2013
- Primary completion
- Jan 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of mepolizumab in Bullous Pemphigoid (BP), sponsored by Insel Gruppe. Started Feb 2013; status: completed.
02
Drugs
mepolizumab
03
Conditions
Bullous Pemphigoid (BP)
Beyond the preview
Go deeper on NCT01705795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01705795.